Induced autologous graft-versus-host disease for the treatment of cancer.
Kennedy
M J
MJ
Johns Hopkins Oncology Center, Baltimore, MD 21287-8936.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D001943:Breast Neoplasms / Q000628:therapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology*; D006801:Humans; D007167:Immunotherapy; D007371:Interferon-gamma / Q000627:therapeutic use; D008223:Lymphoma / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D051381:Rats; D014182:Transplantation, Autologous
D007371:Interferon-gamma; D016572:Cyclosporine